stockrowPrestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- −38.4%
- Free cash flow
- −38.2%
- Total debt
- +100.9%
Quarter to September 2026, against a year earlier
Follow PBH
Alert me
Prestige Consumer Healthcare Inc. (PBH) Return on invested capital
Prestige Consumer Healthcare Inc.'s return on invested capital over the twelve months to 30 September 2026 was 9.59%, up 2.8 percentage points from fiscal 2026 (6.82%). Over the past ten years it has ranged from −0.51% (fiscal 2023) to 7.83% (fiscal 2024); the current reading is higher than 75% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | 6.82% | (0.83) |
| FY2025 | 7.65% | (0.18) |
| FY2024 | 7.83% | 8.34 |
| FY2023 | −0.51% | (7.31) |
| FY2022 | 6.80% | 0.19 |
| FY2021 | 6.61% | 0.14 |
| FY2020 | 6.47% | 5.00 |
| FY2019 | 1.47% | (2.82) |
| FY2018 | 4.29% | (0.03) |
| FY2017 | 4.32% | (2.63) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| XERS Xeris Biopharma Holdings, Inc. compare | 27.2% |
| PBH Prestige Consumer Healthcare Inc. | 9.59% |
| TRLV Trulieve Cannabis Corp. compare | 0.00% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.00% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.00% |
| RGC Regencell Bioscience Holdings Limited compare | 0.00% |
| ALVO Alvotech compare | 0.00% |
| BCRX BioCryst Pharmaceuticals, Inc. compare | 0.00% |
| PRGO Perrigo Company plc compare | −19.0% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on PBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement